Introduction to the regulation of medicinal products—EU

Copyright © 2025 LexisNexis
Published by a LexisNexis EU Law expert
Practice notes

Introduction to the regulation of medicinal products—EU

Copyright © 2025 LexisNexis

Published by a LexisNexis EU Law expert

Practice notes
imgtext

EU legal framework governing medicinal products

A complex array of requirements and guidelines developed at EU and EU Member State national level govern the following aspects of medicinal products:

  1. •

    clinical testing (ie clinical trials)

  2. •

    placing on the market (ie marketing authorisation (MA) and regulatory procedure for approval of medicinal products and variations of those licensing MAs)

  3. •

    protection of the pre-clinical and clinical data developed for the purposes of obtaining an MA (ie regulatory data protection)

  4. •

    manufacture and importation

  5. •

    labelling and package leaflet

  6. •

    advertising and promotion

  7. •

    wholesale distribution and brokering

  8. •

    pharmacovigilance

  9. •

    pricing and reimbursement

  10. •

    falsified medicines

  11. •

    medicines for rare diseases (ie orphan medicinal products (OMPs))

  12. •

    paediatric medicines

  13. •

    advanced therapy medicinal products (ATMPs)

  14. •

    unlicensed medicines and off-label use of authorised medicines

EU legal framework

There has been a rapid expansion of law on these subjects at the EU level, with increased harmonisation in many areas. EU Member State requirements and guidelines still, however, remain essential parts of the EU regulatory picture. There are

Powered by Lexis+®
Jurisdiction(s):
European Union

Popular documents

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

Late payment penalties—inheritance tax

Late payment penalties—inheritance taxWhile interest often accrues on overdue tax, the late payment of certain taxes may also attract a penalty. For information on the interest accruing on overdue tax, see Practice Notes: IHT—payment deadlines on death—Interest on IHT and Interest on late paid

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal

If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an